CVR: 41142871
DKK -60,636,000
Gross profit
Net result: DKK -125,695,000
Novo Holdings A/S, Sanofi Foreign Participations B.V.
5 more
CVR · view ownership and management
Director role ended: Rita Balice-Gordon
CVR · 26/06/2026
View the full event history
Muna Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Michel Marcel A. Detheux. The company's owners include Novo Holdings A/S, Sanofi Foreign Participations B.V. and Axxam S.p.A.. In 2025, the company reported a gross profit of DKK -60,636,000 and a net result of DKK -125,695,000 compared with DKK -173,625,357 the year before. Equity in the 2025 report amounted to DKK -120,338,000.
Selskabets formål er at forske i, udvikle, producere og sælge bioteknologiske produkter og medicinalprodukter samt anden virksomhed, der efter ledelsens skøn er forbundet dermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -60.6 mio. | -125.7 mio. | 311.1 mio. | -120.3 mio. | 18 | |
| 202401/01/2024 – 31/12/2024 | -124.7 mio. | -173.6 mio. | 175 mio. | 18.7 mio. | 18 | |
| 202301/01/2023 – 31/12/2023 | -110.6 mio. | -140.3 mio. | 168.2 mio. | 127 mio. | 18 | |
| 202201/01/2022 – 31/12/2022 | -98.2 mio. | -127.7 mio. | 247.5 mio. | 202 mio. | 16 | |
| 202101/01/2021 – 31/12/2021 | -49.7 mio. | -61.5 mio. | 184.1 mio. | 162.3 mio. | 7 | |
| 202022/01/2020 – 31/12/2020 | -7.3 mio. | -7.4 mio. | 24.3 mio. | 16.7 mio. | 3 |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringMuna Therapeutics ApS was founded on 22 January 2020.
Muna Therapeutics ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
The owners of Muna Therapeutics ApS include Novo Holdings A/S, Sanofi Foreign Participations B.V. and Axxam S.p.A..
In 2025, Muna Therapeutics ApS reported a gross profit of DKK -60,636,000.
The management of Muna Therapeutics ApS consists of Michel Marcel A. Detheux.
Muna Therapeutics ApS is located at Nordre Fasanvej 215, 2000 Frederiksberg.
Claim this page to add your logo and social links. Free to get started.
As of August 12, 2026, Michel Marcel A. Detheux has joined the board of directors of Muna Therapeutics ApS.
As of June 26, 2026, Michel Marcel A. Detheux is registered as adm. dir. of Muna Therapeutics ApS.
As of June 26, 2026, Rita Balice-Gordon has stepped down as adm. dir. of Muna Therapeutics ApS.
Muna Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -60,636,000, and the net result was DKK -125,695,000.
As of October 27, 2025, EY Godkendt Revisionspartnerselskab has been appointed auditor of Muna Therapeutics ApS.
As of October 27, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Muna Therapeutics ApS.
Muna Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -124,745,897, and the net result was DKK -173,625,357.
As of March 11, 2025, Luc Madeleine Albert Dochez has joined the board of directors of Muna Therapeutics ApS.
As of February 1, 2025, Reza Halse has left the board of directors of Muna Therapeutics ApS.
As of January 30, 2025, Camilla Petrycer Hansen has joined the board of directors of Muna Therapeutics ApS.
As of January 30, 2025, Morten Døssing has left the board of directors of Muna Therapeutics ApS.
Muna Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -110,624,445, and the net result was DKK -140,319,972.
As of November 27, 2023, Novo Holdings A/S is registered as an owner of Muna Therapeutics ApS with an ownership share of 15%.
As of November 15, 2023, Reza Halse has joined the board of directors of Muna Therapeutics ApS.
As of November 15, 2023, Luc Dochez has left the board of directors of Muna Therapeutics ApS.
Muna Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -98,234,040, and the net result was DKK -127,682,346.
As of June 30, 2022, is registered as an owner of Muna Therapeutics ApS with an ownership share of 5%.
As of June 30, 2022, is registered as an owner of Muna Therapeutics ApS with an ownership share of 5%.
As of June 30, 2022, is registered as an owner of Muna Therapeutics ApS with an ownership share of 15%.
Muna Therapeutics ApS has published its annual report for 2021. Gross profit came to DKK -49,692,746, and the net result was DKK -61,518,260.
As of June 1, 2022, Eileen Elizabeth McGuire has joined the board of directors of Muna Therapeutics ApS.
As of June 1, 2022, Isaac Ciechanover has left the board of directors of Muna Therapeutics ApS.
As of September 15, 2021, Morten Døssing has joined the board of directors of Muna Therapeutics ApS.
As of September 15, 2021, Donald William Nicholson has joined the board of directors of Muna Therapeutics ApS.
As of September 14, 2021, Morten Døssing has left the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Henrijette Elsebeth Richter has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Rita Balice-Gordon has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Cillian King has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Luc Dochez has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Laia Crespo-Martin has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Isaac Ciechanover has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Anders Mørkeberg Hinsby has left the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Camilla Petrycer Hansen has left the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Joachim Pold Vilstrup has left the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Stefan Lohmer has left the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Chiara Rossana Maria Liberati has left the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Rita Balice-Gordon is registered as adm. dir. of Muna Therapeutics ApS.
As of July 8, 2021, Anders Mørkeberg Hinsby has stepped down as adm. dir. of Muna Therapeutics ApS.
As of July 8, 2021, is registered as an owner of Muna Therapeutics ApS with an ownership share of 5%.
As of July 8, 2021, is registered as an owner of Muna Therapeutics ApS with an ownership share of 15%.
As of July 8, 2021, is registered as an owner of Muna Therapeutics ApS with an ownership share of 5%.
Muna Therapeutics ApS has published its annual report for 2020. Gross profit came to DKK -7,345,098, and the net result was DKK -7,382,109.
As of March 19, 2021, Chiara Rossana Maria Liberati has joined the board of directors of Muna Therapeutics ApS.
As of December 29, 2020, Stefan Lohmer has joined the board of directors of Muna Therapeutics ApS.
As of October 12, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Muna Therapeutics ApS.
As of October 12, 2020, A/S PSE 17 NR. 1056 has stepped down as auditor of Muna Therapeutics ApS.
As of September 16, 2020, Joachim Pold Vilstrup has joined the board of directors of Muna Therapeutics ApS.
As of September 16, 2020, Simon Glerup Pedersen has left the board of directors of Muna Therapeutics ApS.
As of June 3, 2020, Anders Mørkeberg Hinsby has joined the board of directors of Muna Therapeutics ApS.
As of June 3, 2020, Camilla Petrycer Hansen has joined the board of directors of Muna Therapeutics ApS.
As of June 3, 2020, Simon Glerup Pedersen has joined the board of directors of Muna Therapeutics ApS.
As of June 3, 2020, Morten Døssing has joined the board of directors of Muna Therapeutics ApS.
As of June 3, 2020, Peder Søndergaard Madsen has left the board of directors of Muna Therapeutics ApS.
As of June 1, 2020, Anders Mørkeberg Hinsby is registered as adm. dir. of Muna Therapeutics ApS.
As of June 1, 2020, Joachim Pold Vilstrup has stepped down as adm. dir. of Muna Therapeutics ApS.
As of January 22, 2020, A/S PSE 17 NR. 1056 has been appointed auditor of Muna Therapeutics ApS.
As of January 22, 2020, Peder Søndergaard Madsen has joined the board of directors of Muna Therapeutics ApS.
As of January 22, 2020, Joachim Pold Vilstrup is registered as adm. dir. of Muna Therapeutics ApS.
Muna Therapeutics ApS was founded on January 22, 2020.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583
